How has Lexicon Pharmaceuticals's number of reportable segments changed year-over-year?

Lexicon Pharmaceuticals's number of reportable segments decreased by 0.0% year-over-year, from 1 to 1.

What does number of reportable segments mean?

The total count of distinct business units or product lines for which the company reports separate financial results. This metric reflects the organizational structure and the diversity of the company's operational focus.

Lexicon Pharmaceuticals LXRX Number of reportable segments

Number of reportable segments at other companies

Ionis PharmaceuticalsIONS

1+300%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NumberOfReportableSegments.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's number of reportable segments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's number of reportable segments?: Lexicon Pharmaceuticals (LXRX) reported number of reportable segments of 1 in Q1 2026.
How has Lexicon Pharmaceuticals's number of reportable segments changed year-over-year?: Lexicon Pharmaceuticals's number of reportable segments decreased by 0.0% year-over-year, from 1 to 1.
What does number of reportable segments mean?: The total count of distinct business units or product lines for which the company reports separate financial results. This metric reflects the organizational structure and the diversity of the company's operational focus.